Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2
https://doi.org/10.20996/1819-6446-2018-14-6-846-851
Abstract
About the Authors
V. V. SkibitskiyRussian Federation
MD, PhD, Professor, Head of Chair of Hospital Therapy
A. A. Kiselev
Russian Federation
MD, Assistant, Chair of Hospital Therapy
A. V. Fendrikova
Russian Federation
MD, PhD, Associate Professor, Chair of Hospital Therapy
References
1. Chazova I.E., ZhernakovaYu.V., Oshchepkova E.V. et al. Prevalence of Cardiovascular Risk Factors in Russian Population of Patients With Arterial Hypertension. Kardiologia. 2014;10:4-12. (In Russ.)
2. Rydén L., Grant P.J., Anker S.D. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035-87. doi:10.1093/eurheartj/eht108.
3. London G.M., Asmar R.G., O’Rourke M.F., Safar M.E. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99. doi:10.1016/j.jacc.2003.07.039.
4. Williams B., Lacy P.S., Thom S.M. et al. Differential impact of blood pressurelowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-25. doi:10.1161/CIRCULATIONAHA.105.595496.
5. Qi H., Liu Z., Cao H. et al. Comparative Efficacy of Antihypertensive Agents in Salt-Sensitive Hypertensive Patients: A Network Meta-Analysis. Am J Hypertens. 2018;31(7):835-46. doi:10.1093/ ajh/hpy027.
6. Isobe-Sasaki Y., Fukuda M., Ogiyama Y. et al. Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy. Physiological Reports. 2017;5(11):e13309. doi:10.14814/phy2.13309.
7. Kharchenko V.I., Luce V.A., Rifai M.A. et al. Salt, water stress and water-sodium metabolism in patients with essential hypertension. Terapevticheskii Arkhiv. 1984;56(12):48-55. (In Russ.)
8. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38. doi:10.1097/HJH.0b013e328364ca4c.
9. Vasyuk Y.A., Ivanova S.V., Shkolnik E.L. et al. Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice. Cardiovascular Therapy and Prevention. 2016;15(2):4-19. (In Russ.)
10. Ohashi N., Isobe S., Ishigaki S., Yasuda H. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney. Hypertens Res. 2017;40(5):413-422. doi:10.1038/hr.2016.166.
11. Combe R., Mudgett J., El Fertak L. et al. How Does Circadian Rhythm Impact Salt Sensitivity of Blood Pressure in Mice? A Study in Two Close C57Bl/6 Substrains. PLoS One. 2016;11(4):e0153472. doi:10.1371/journal.pone.0153472
12. Harvey A., Montezano A.C., Lopes R.A. et al. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol 2016; 32:659-68. doi:10.1016/ j.cjca.2016.02.070.
13. Kotovskaya Yu.V., Kobalava Zh.D. Aortic pressure: modern views on the clinical and prognostic value of its indicators. Meditsinskii Sovet. 2013;4:26-33. (In Russ.)
Review
For citations:
Skibitskiy V.V., Kiselev A.A., Fendrikova A.V. Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2. Rational Pharmacotherapy in Cardiology. 2018;14(6):846-851. https://doi.org/10.20996/1819-6446-2018-14-6-846-851